Hologic, Inc. (VIE:HOLX)

Market Cap	14.10B -7.8%
Revenue (ttm)	3.51B +2.2%
Net Income	462.23M -26.9%
EPS	2.04 -23.8%
Shares Out	n/a
PE Ratio	30.51
Forward PE	16.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	63.50
Previous Close	63.50
Day's Range	63.50 - 63.50
52-Week Range	46.20 - 70.00
Beta	n/a
RSI	43.76
Earnings Date	Jan 29, 2026

About Hologic

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 1985
• Employees: 7,070
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: HOLX

Financial Performance

In fiscal year 2025, Hologic's revenue was $4.10 billion, an increase of 1.74% compared to the previous year's $4.03 billion. Earnings were $565.70 million, a decrease of -28.35%.

Financial numbers in USD